The goal of this clinical trial is to determine whether adding a β-glucan moisturizing cream to routine skin care can enhance skin healing, accelerate visible recovery, reduce discomfort, and improve both patient and clinician experiences. The study will also learn about the safety and tolerability of the β-glucan cream when used along with standard skin care.
The main questions it aims to answer are:
Are there visible changes in the severity of IAD when β-glucan cream is added to standard care, and if so, to what extent does it reduce severity compared with standard care alone?
Does the β-glucan cream help IAD heal faster?
Does the cream reduce symptoms such as pain, itching, tingling, or burning?
What medical problems or side effects, if any, do participants experience while using the β-glucan cream?
Researchers will compare standard care plus β-glucan cream to standard care alone to see if the β-glucan cream provides additional benefit for treating IAD.
Participants will:
Receive either β-glucan cream plus standard care or standard care alone
Have the study cream applied once daily for up to 2 weeks
Have their skin checked weekly by the study team using a standardized assessment tool
Answer questions about symptoms such as pain, itching, tingling, and burning
Allow photographs of the affected skin area to be taken for secure clinical review
Be monitored for any side effects or skin reactions during the study
None
None